Ribera JM, Morgades M, Garcia-Calduch O, Sirvent M, et al. Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial. Haematologica 2023 Aug 10. doi: 10.3324/haematol.2023.283342.
PMID: 37560813